Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
81 participants
INTERVENTIONAL
2007-01-31
2008-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
phytalgic
3/day
2
placebo
3/Day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
phytalgic
3/day
placebo
3/Day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* regular NSAIDs/analgesic treatment
* signed inform consent
Exclusion Criteria
* irregular NSAID treatment
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
laboratoire Phythea, France
UNKNOWN
Université Victor Segalen Bordeaux 2
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dept of pharmacology, CHU Bordeaux
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicholas Moore, MD, PhD
Role: STUDY_DIRECTOR
University of Bordeaux
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept of Pharmacology, U-Bordeaux2, BP36
Bordeaux, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Jacquet A, Girodet PO, Pariente A, Forest K, Mallet L, Moore N. Phytalgic, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial. Arthritis Res Ther. 2009;11(6):R192. doi: 10.1186/ar2891. Epub 2009 Dec 16.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PhytalgicOA
Identifier Type: -
Identifier Source: org_study_id